CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphoma

International Journal of Hematology

Volumn 81, Issue 4, 2005, Pages 315-318

  Fujisawa, Shinya ^a   Tanioka, Fumihiko ^b   Matsuoka, Toshihiko ^a   Ozawa, Takachika ^a  

^a HAMAMATSU MEDICAL CENTER   (Japan)

^b Iwata Municipal General Hospital   (Japan)

Author keywords

c myc IgH rearrangement; CD5; Diffuse large B cell lymphoma; Primary effusion lymphoma

Indexed keywords

BLEOMYCIN; CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IMMUNOGLOBULIN HEAVY CHAIN; LACTATE DEHYDROGENASE; METHOTREXATE; MYC PROTEIN; PIRARUBICIN; PREDNISOLONE; PROTEIN BCL 2; VINCRISTINE; IMMUNOGLOBULIN;

ACUTE HEART FAILURE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; PERICARDIAL EFFUSION; POLYMERASE CHAIN REACTION; PRIMARY EFFUSION LYMPHOMA; B CELL LYMPHOMA; GENE REARRANGEMENT; GENETICS; ONCOGENE MYC; PATHOLOGY; PLEURA EFFUSION;

AGED; ANTIGENS, CD5; GENE REARRANGEMENT; GENES, MYC; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PERICARDIAL EFFUSION; PLEURAL EFFUSION;

EID: 22844444911     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04155     Document Type: Article

References (17)

1. Yamaguchi M, Ohno T, Oka K, et al. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Brit J Haematol 1999;105:1133-1139.
2. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5 diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
3. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA. 1982;79:7824-7827.
4. Taub R, Kirsch I, Morton C, et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA. 1982;79:7837-7841.
5. Akasaka T, Akasaka H, Ueda C, et al. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-myc/immunoglobulin heavy-chain fusion gene. J Clin Oncol. 2000;18:510-518.
6. Yunis JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken MM, Frizzera G. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. New Engl J Med. 1989;320:1047-1054.
7. Kramer MHH, Hermans J, Wijburg E, et al. Clinical relevance of bcl2, bcl6, and myc rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152-3162.
8. Akasaka T, Yonetani N, Akasaka H, Ohno H, Okuma M. Detection of t(8;14)(q24;q32) by polymerase chain reaction for long DNA targets: a report of two patients with B-cell non-Hodgkin's lymphoma. Int J Hematol 1998;67:75-79.
9. Lin CW, O'Brien S, Faber J, et al. De novo CD5+ Burkitt lymphoma/leukemia. Am J Clin Pathol. 1999;112:828-835.
10. Niwano H, Aoki S, Tsukada N, et al. An aggressive case of Burkitt's lymphoma with t(8;14) and c-myc rearrangement transformed from CD5+ B-cell lymphoma. Ann Haematol. 1997;75:221-225.
11. Ashihara E, Shimazaki C, Hirai H, et al. Human herpes virus 8-negative primary effusion lymphoma in a patient with a ventriculoperitoneal shunt tube. Int J Hematol. 2001;74:327-332.
12. Ohshima K, Ishiguro M, Yamasaki S, et al. Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients. Leuk Lymphoma. 2002;43:595-601.
13. Ichinohasama R, Miura I, Kobayashi N, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998;22:1528-1537.
14. Shimazaki M, Fujita M, Tsukamoto K, et al. An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8. Eur J Haematol. 2003;71:62-67.
15. Ascoli V, Coco FL, Artini M, Levrero M, Fruscalzo A, Mecucci C. Primary effusion Burkitt's lymphoma with t(8;22) in a patient with hepatitis C virus-related cirrhosis. Hum Pathol. 1997;28:101-104.
16. Hermine O, Michel M Buzyn-Veil A, Gessain A. Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. New Engl J Med. 1996;334:272-273.
17. Nakamura N, Nakamine H, Tamaru J, et al. The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-myc rearrangement. Mod Pathol. 2002;15:771-776.